FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/28/2022
Back to search
Official data from USPTO
QUVIVIQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
02/28/2022
Trademark type
Combined
Nice classes
5
Filing date
10/08/2020
Registration date
08/24/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/24/2021
Last transaction
08/24/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
RUSKIN, MATTHEW SEAN
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "QUVIVIQ" with a shaded triangle appearing under the letters "VIV".
Holders and representatives
Holders
Idorsia Pharmaceuticals Ltd
Representatives
Mary Margaret L. O'Donnell Blue Filament Law PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseaseshypertensionbrain haemorrhage and sequelae thereofkidney diseasespulmonary diseasesfibrotic diseasescystic fibrosisinflammatory diseasesallergic diseasesauto-immune diseases and disordersneurodegenerative diseases and disordersneurological diseases and disordersdiseases and disorders of the central nervous systemdementiasleep disordersanxiety disordersaddictionseating disordersepilepsymetabolic disordersdiabetesglycolipid storage disordersFabry disease and symptoms and sequelae of Fabry diseaseinfectious diseasescancer
Publications
History of USPTO decisions and trademark events.
27 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/08/2022
FIMP
FINAL DISPOSITION PROCESSED
02/08/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/24/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/24/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/08/2021
PUBO
PUBLISHED FOR OPPOSITION
06/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/19/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/27/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/27/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/27/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/27/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/27/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/27/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/27/2021
RFNT
REFUSAL PROCESSED BY IB
04/05/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/18/2021
RFRR
REFUSAL PROCESSED BY MPU
03/18/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/16/2021
CNRT
NON-FINAL ACTION WRITTEN
03/15/2021
DOCK
ASSIGNED TO EXAMINER
03/08/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/10/2020
Continuous trademark protection
Get notified about every new filing that threatens QUVIVIQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.